Funding backs a human-first approach to drug safety and efficacy, reducing reliance on animal testing and accelerating ...

Medicinal chemistry, also known as pharmaceutical chemistry, is a branch of chemistry focused on the development of new drugs and the improvement of existing ones. It is an interdisciplinary field ...

Glucagon-like peptide agonists (GLP-1s, like Ozempic, Wegovy, and Mounjaro) have been hailed as breakthroughs. From statins to Viagra, occasionally a drug development breakthrough occurs that is ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

Drug discovery has traditionally been slow and expensive, often taking decades and costing manufacturers billions. Traditional methods, while advancing, are hitting limits in tackling the complexities ...

In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...

Excelsior Sciences said on Wednesday it has raised $95 million to develop technology that uses machines and artificial ...

The Physicians Committee for Responsible Medicine applauds the Food and Drug Administration’s newly released draft guidance, ...

One of the pillars of modern medicine is the life-saving drugs that pharmaceutical companies spend years developing to cure and prevent diseases. But what if they could do it faster and at a fraction ...

From groundbreaking treatments for chronic and infectious diseases and innovative therapies targeting previously untreatable conditions to advances in personalized and precision medicine, the pursuit ...

FDA proposals include ‘major updates’ to simplify biosimilarity studies, reduce unnecessary clinical testing, and ease the ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...